Search

Your search keyword '"Zomorodian, Kamiar"' showing total 635 results

Search Constraints

Start Over You searched for: Author "Zomorodian, Kamiar" Remove constraint Author: "Zomorodian, Kamiar"
635 results on '"Zomorodian, Kamiar"'

Search Results

254. The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran

255. Successful treatment of pulmonary aspergillosis due to Aspergillus fumigatus in a child affected by systemic lupus erythematosus: A case report from Northeastern Iran.

257. Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrataRecovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of PDR1

259. Evaluation of building washing machines as an extreme environment for potentially pathogenic fungi.

264. Chemical Composition and Antifungal and Antibiofilm Effects of Vitex pseudo-negundo Essential Oil against Pathogenic Fungal Strains.

265. Species identification, antifungal susceptibility patterns, and vitamin D3 level in women with vaginal candidiasis: a case–control study in Iran.

266. Design and Antifungal Activity of Fluconazole and Nystatin Loaded Onto Silica Mesoporous.

268. [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studies.

271. Clinical evaluation of β-tubulin real-time PCR for rapid diagnosis of dermatophytosis, a comparison with mycological methods.

272. Using the supercritical carbon dioxide as the solvent of Nystatin: Studying the effect of co-solvent, experimental and correlating.

273. Synthesis and structure–activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.

274. New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation.

275. Time and cost‐efficient identification of Trichophyton indotineae.

276. Quantitative analysis of in vitro biofilm formation by clinical isolates of dermatophyte and antibiofilm activity of common antifungal drugs.

277. Magnetic chitosan nanoparticles loaded with Amphotericin B: Synthesis, properties and potentiation of antifungal activity against common human pathogenic fungal strains.

278. Development of a recombinant nucleocapsid protein‐based ELISA for the detection of IgM and IgG antibodies to SARS‐CoV‐2.

279. Synthesis and bioactivities evaluation of quinazolin-4(3H)-one derivatives as α-glucosidase inhibitors.

280. Synthesis, antifungal activity and docking study of 2-amino-4H-benzochromene-3-carbonitrile derivatives.

281. Chemical Composition, Antifungal and Antibiofilm Activities of the Essential Oil of Mentha piperita L.

282. Antimicrobial and Anti-Biofilm Activities of Thymus fallax Essential Oil against Oral Pathogens.

284. Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activity.

285. B-Cell Epitope Mapping from Eight Antigens of Candida albicans to Design a Novel Diagnostic Kit: An Immunoinformatics Approach.

286. COVID‐19‐associated facial cutaneous mucormycosis superinfection: A potentially life‐threatening disease.

287. Evaluation of the Distribution of Candida Species in Patients with Dysplastic and Nondysplastic Oral Lichen Planus Lesions.

288. Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents.

289. In vitro antifungal susceptibility patterns of Trichophytonbenhamiae complex isolates from diverse origin.

290. Molecular characterization and antifungal activity against non-dermatophyte molds causing onychomycosis.

292. Characterization and Physical and Biological Properties of Tissue Conditioner Incorporated with Carum copticum L.

293. MALDI‐TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.

294. Dissolvable carboxymethyl cellulose/polyvinylpyrrolidone microneedle arrays for transdermal delivery of Amphotericin B to treat cutaneous leishmaniasis.

295. Evaluation of Antimicrobial and Antibiofilm Activities of Copper Oxide Nanoparticles within Soft Denture Liners against Oral Pathogens.

296. Potential Pathogenicity of Candida Species Isolated from Oral Cavity of Patients with Diabetes Mellitus.

297. Protective Effects of the Probiotic Bacterium Streptococcus thermophilus on Candida albicans Morphogenesis and a Murine Model of Oral Candidiasis.

300. Glucantime-loaded electrospun core-shell nanofibers composed of poly(ethylene oxide)/gelatin-poly(vinyl alcohol)/chitosan as dressing for cutaneous leishmaniasis.

Catalog

Books, media, physical & digital resources